Philip Morris International Inc (PM) 97.92 $PM Supreme

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Philip Morris International Inc (PM) 97.92 $PM

Supreme Court rejects appeal from Illinois smokers
AP - Mon Jun 20, 4:33PM CDT
WASHINGTON (AP) — The Supreme Court on Monday rejected an appeal from Illinois smokers who sought reinstatement of a $10.1 billion class-action judgment in a long-running lawsuit against Philip Morris.
PM: 97.92 (-3.98), MO: 67.48 (+1.17)

J.M. Smucker, Baidu, Altria Group, Reynolds American and Philip Morris International highlighted as Zacks Bull and Bear of the Day
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 8:30AM CDT
J.M. Smucker, Baidu, Altria Group, Reynolds American and Philip Morris International highlighted as Zacks Bull and Bear of the Day
RAI: 51.45 (+0.61), PM: 97.92 (-3.98), BIDU: 159.66 (-4.26), MO: 67.48 (+1.17), SJM: 145.81 (-0.75)

Altria versus Reynolds: Tobacco Stock On Fire in Volatility
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 9:03AM CDT
The U.S. market is on a roller coaster ride with recent events spiking up volatility.
RAI: 51.45 (+0.61), PM: 97.92 (-3.98), MO: 67.48 (+1.17)

Cigarettes Stocks Technical Analysis -- Altria Group, Reynolds American, Philip Morris Intl., and Vector Group
PR Newswire - Thu Jun 16, 7:00AM CDT
On Wednesday, June 15, 2016, the NASDAQ Composite ended the trading session at 4,834.93, down 0.18%; the Dow Jones Industrial Average edged 0.20% lower to finish at 17,640.17; and the S&P 500 closed at 2,071.50, down 0.18%. However, six out of nine sectors ended the session in positive. Stock-Callers.com has initiated coverage on the following equities: Altria Group Inc. (NYSE: MO), Reynolds American Inc. (NYSE: RAI), Philip Morris International Inc. (NYSE: PM), and Vector Group Ltd (NYSE: VGR). Learn more about these stocks by accessing their free trade alerts at:
RAI: 51.47 (+0.63), PM: 97.93 (-3.97), MO: 67.48 (+1.17), VGR: 21.74 (-0.05)

Illicit Tobacco Trade Alarmingly High, EU Consumes 53M
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 8:51AM CDT
The latest cigarette trafficking reports have irked the tobacco industry further which has already been grappling with issues like dwindling volumes and high excise taxes.
RAI: 51.47 (+0.63), PM: 97.93 (-3.97)

Philip Morris International (PMI) Declares Regular Quarterly Dividend of $1.02 Per Share
BusinessWire - Thu Jun 09, 3:21AM CDT
Regulatory News:
PM: 97.93 (-3.97)

Will Global Worries Weigh on Consumer Staples Companies?
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 4:28PM CDT
Will Global Worries Weigh on Consumer Staples Companies?
RAI: 51.47 (+0.63), KO: 44.14 (-0.94), MDLZ: 42.28 (-2.57), KMB: 131.73 (-2.23), UL: 44.37 (-3.02), MO: 67.48 (+1.17), DEO: 104.56 (-5.20), K: 77.50 (-0.33), SJM: 145.81 (-0.75), PEP: 102.49 (-1.95), DPS: 92.48 (-0.09), PM: 97.93 (-3.97), NUS: 45.21 (-2.33), PF: 43.58 (-0.58), PG: 82.48 (-1.73), EL: 90.07 (-4.88), GIS: 66.38 (-0.39)

Are Consumer Staples Stocks Poised for Strong Growth?
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 3:56PM CDT
Are Consumer Staples Stocks Poised for Strong Growth?
MDLZ: 42.28 (-2.57), MKC: 101.90 (-0.50), CAG: 46.95 (-0.96), THS: 97.24 (-1.42), KMB: 131.73 (-2.23), SYY: 49.89 (-0.40), WMT: 72.12 (+0.02), PEP: 102.49 (-1.95), K: 77.50 (-0.33), DPS: 92.48 (-0.09), TGT: 69.43 (-0.35), DF: 17.48 (-0.10), RAI: 51.47 (+0.63), KO: 44.14 (-0.94), HYH: 32.37 (-1.12), BUD: 122.88 (-6.70), JJSF: 113.15 (-0.38), TAP: 98.50 (-3.45), MO: 67.48 (+1.17), WWAV: 44.39 (-2.30), PM: 97.93 (-3.97), UNFI: 45.11 (-0.63), BGS: 46.82 (+0.17), TJX: 75.00 (-1.88), KHC: 84.12 (-2.25), MCD: 119.90 (-1.31), PF: 43.58 (-0.58), PG: 82.48 (-1.73), GIS: 66.38 (-0.39)

53 billion illegal cigarettes consumed in the European Union last year
BusinessWire - Wed Jun 08, 4:02AM CDT
--Non-EU contraband and counterfeit increased to 88%
PM: 97.93 (-3.97)

Consumer Staples Stock Outlook - June 2016
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 2:17PM CDT
Consumer Staples Stock Outlook - June 2016
KO: 44.14 (-0.94), PM: 97.93 (-3.97), MKC: 101.90 (-0.50), THS: 97.24 (-1.42), SYY: 49.89 (-0.40), SAM: 161.46 (+0.35), MO: 67.48 (+1.17), TSN: 63.75 (+0.39), PEP: 102.49 (-1.95)

SmarTrend Watching for Potential Pullback in Shares of Philip Morris After 1.80% Gain
Comtex SmarTrend(R) - Fri Jun 03, 12:50PM CDT
Philip Morris (NYSEM) traded in a range yesterday that spanned from a low of $99.51 to a high of $101.10. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $99.60 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PM: 97.93 (-3.97)

Watch for Shares of Philip Morris (PM) to Approach Resistance at $99.65
Comtex SmarTrend(R) - Fri Jun 03, 8:40AM CDT
Philip Morris (NYSEM) has opened bullishly above the pivot of $99.17 today and has reached the first level of resistance at $99.46. Analysts will be watching for a cross of the next upside pivot targets of $99.65 and $100.14.
PM: 97.93 (-3.97)

Stock Market News for June 02, 2016
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 9:10AM CDT
Despite lackluster global manufacturing reports, benchmarks finished in the green following a late recovery in oil prices and higher-than-expected U.S. manufacturing data.
PM: 97.93 (-3.97), F: 12.50 (-0.90), GM: 28.41 (-1.41), COST: 155.86 (-1.17), XOM: 89.81 (-1.99), KORS: 47.69 (-3.13), PG: 82.48 (-1.73), MO: 67.48 (+1.17), CVX: 102.30 (-2.14)

White House Rejects FDA Plans for Flavored e-Cigarettes
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 3:38PM CDT
Tobacco companies may heave a sigh of relief as the White House has reportedly decided to exclude e-cigarettes from a recent anti-tobacco regulation proposed by The Food and Drug Administration (FDA).
RAI: 51.47 (+0.63), PM: 97.93 (-3.97), MO: 67.48 (+1.17)

New Zealand Proceeds with Plain Cigarette Packaging Plans
Zacks Equity Research - Zacks Investment Research - Tue May 31, 9:36AM CDT
Tobacco makers faced yet another jolt after companies in New Zealand were asked to remove logos from cigarette packets and also enlarge the health warnings on the packages.
RAI: 51.47 (+0.63), BTI: 120.17 (-6.98), PM: 97.93 (-3.97)


New Zealand plans to remove logos from cigarette packs
By NICK PERRY - AP - Mon May 30, 11:17PM CDT
WELLINGTON, New Zealand (AP) — New Zealand on Tuesday announced it will push ahead with plans to force tobacco companies to remove their logos from cigarette packs and enhance graphic health warnings.
PM: 97.93 (-3.97)

Philip Morris to Fight Illicit Tobacco Trade, Fund Projects
Zacks Equity Research - Zacks Investment Research - Mon May 30, 5:54AM CDT
Tobacco major Philip Morris International Inc. (PM) has come up with a new initiative, PMI IMPACT, to combat illicit trade practices.
RAI: 51.46 (+0.62), PM: 97.92 (-3.98), MO: 67.48 (+1.17), VGR: 21.74 (-0.05)

Philip Morris International Launches New Initiative to Fight Smuggling and Related Crimes; Pledges USD 100 Million to Fund Projects
BusinessWire - Fri May 27, 6:06AM CDT
Philip Morris International Inc. (PMI) (NYSE /Euronext Paris: PM) announced today a major new initiative -- "PMI IMPACT" -- to help confront smuggling and related crimes.
PM: 97.92 (-3.98)

Could the World's Most Effective Quit Smoking Aid be a Low Nicotine Cigarette? US Public Health Officials Think So
ACCESSWIRE - Wed May 25, 8:39AM CDT
More Than 16 Million Americans Attempt To Quit Smoking Each Year without the Use of Drugs or Therapies--And Only 2-5% Successfully Quit In A Given Year; 22nd Century Group (NYSE MKT: XXII) Is Developing the Most Effective Solution to Date for These "Marooned" Consumers
PM: 97.92 (-3.98), XXII: 0.81 (-0.02), PFE: 34.07 (-0.52), GSK: 40.93 (-1.63)

Watch for Shares of Philip Morris (PM) to Approach Resistance at $98.83
Comtex SmarTrend(R) - Tue May 24, 8:41AM CDT
Shares of Philip Morris (NYSEM) opened today above their pivot of $98.14 and have already reached the first level of resistance at $98.56. Should the shares continue to rise, the resistance pivots of $98.83 and $99.52 will be of interest.
PM: 97.92 (-3.98)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 13

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 14

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 14

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 15

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 14

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Telehealth Trends: A Comprehensive Yearly Insight

Updated Category News Views 346

FAIR Health's Telehealth Tracker: A Milestone Year FAIR Health has reached a significant milestone with its Monthly Telehealth Regional Tracker entering its sixth year. This tracker provides valuable insights into how telehealth usage has evolved, empowering stakeholders to understand trends in healthcare delivery. New Features and Data Insights The latest iteration of...

Continue Reading
Exploring Analog Devices: A $1000 Investment Journey

Updated Category News Views 139

The Growth of Analog Devices Inc (NASDAQ: ADI) Investors have increasingly turned their attention to Analog Devices Inc, a leader in the semiconductor industry. Over the last five years, Analog Devices has consistently outperformed the market, showcasing an annualized return of 16.0%. With a current market capitalization standing at an impressive $119.42 billion, the...

Continue Reading
Celebrating Excellence in Clinical Simulation: Meet the Nominees

Updated Category News Views 110

Highlighting Excellence in Clinical Simulation Awards A Representation of the Best in Simulation Healthcare Education in 2024 Education Management Solutions (EMS), a frontrunner in healthcare simulation and competency management platforms, has proudly announced its nominees for the 16th Annual Excellence in Clinical Simulation Awards. Each year, this noteworthy event...

Continue Reading
Significant Oil Price Drop Benefits Airlines and Cruise Lines

Updated Category News Views 195

Oil Prices Experience a Significant Drop Amid Easing Tensions Oil prices witnessed a noticeable decrease recently, plummeting over 5% during early trading in New York. This shift came as geopolitical tensions in the Middle East appeared to stabilize after an assurance from Israeli Prime Minister Benjamin Netanyahu that Iran’s oil facilities would not be targets in any...

Continue Reading
RxSight, Inc. Faces Legal Challenges: Investors Invited to Join Lawsuit

Updated Category News Views 136

RxSight, Inc. Investors Invited to Participate in Class Action Lawsuit Investors of RxSight, Inc. are becoming aware of significant opportunities to engage in a class action lawsuit. This legal action is being initiated by Bronstein, Gewirtz & Grossman, LLC, a law firm with a national reputation for advocating on behalf of investors. They are notifying shareholders that...

Continue Reading